FDA approves new sunscreen ingredient used for years in Europe and Asia

FDA Approves New Sunscreen Ingredient Used for Years in Europe and Asia

FDA approves new sunscreen ingredient used – After two decades of stagnation, the U.S. Food and Drug Administration (FDA) has taken a significant step forward by approving bemotrizinol, or BEMT, as a new sunscreen ingredient. This decision marks the first time a novel UV filter has been sanctioned in the United States since 2004. According to experts, BEMT offers a safer alternative to many of the chemical compounds currently prevalent in American sunscreens, addressing longstanding concerns about ingredient safety and efficacy.

UVA Protection Gap and Consumer Concerns

The approval of BEMT comes amid growing pressure from environmental and health advocates who have long criticized the limited UVA protection provided by U.S. sunscreens. An annual report by the Environmental Working Group (EWG) highlights that only a small fraction of products on store shelves deliver robust UVA defense, despite their SPF labels suggesting broader coverage. This discrepancy has led to frustration among consumers and scientists alike, who argue that the current standards leave users vulnerable to long-term skin damage.

“Sunscreens today are effective at preventing visible sunburns, but they often fall short in protecting against UVA rays, which are deeply penetrating and linked to premature aging, immune suppression, and skin cancer,” explains David Andrews, EWG’s chief science officer. The American Cancer Society corroborates this, noting that UVA radiation plays a central role in the development of skin cancer. To address this, the EWG conducted peer-reviewed research revealing that U.S. sunscreens, on average, provide just 24% of the UVA protection they claim on labels. This finding underscores the urgent need for improved formulations.

A Safer Alternative with Robust Data

BEMT, a chemical filter, stands out for its effectiveness and safety profile. Unlike many traditional UV ingredients, it does not easily penetrate the skin, reducing the risk of systemic absorption. “Bemotrizinol changes the equation for sun care. It remains stable under UV exposure without breaking down, unlike avobenzone, the only non-mineral filter in the U.S. offering meaningful UVA protection,” says Alexa Friedman, a senior scientist at the EWG. She emphasizes that BEMT’s safety data is the most comprehensive available among UV filters, giving it an edge over older chemical counterparts.

“This is a great day for American consumers and everyone who has fought to improve sunscreen options and close the UVA protection gap in U.S. sunscreens,” Andrews stated. “For decades, Americans have used outdated sunscreen tech while the rest of the world moved forward. The approval of bemotrizinol will help change that,” he added.

The FDA’s decision is particularly timely, as it opens the door for manufacturers to incorporate BEMT into their products, potentially increasing market competition. This could lead to more innovative sunscreen options that balance effectiveness with reduced health risks. The agency’s approval also aligns with a broader trend toward reevaluating the safety of commonly used chemicals, following a 2019 study that found six popular UV filters could enter the bloodstream at concerning levels after just one day of use.

Mineral vs. Chemical Sunscreens: A Growing Divide

While BEMT represents a chemical advancement, its approval complements the existing use of mineral-based sunscreens, which rely on ingredients like zinc oxide and titanium dioxide. These minerals sit on the skin’s surface, physically deflecting UV rays rather than absorbing them. As a result, they are less likely to cause irritation or toxicity, making them a preferred choice for many, especially those with sensitive skin.

However, chemical sunscreens have traditionally been favored for their lightweight texture and non-greasy finish. The EWG’s 2026 report reveals that 497 of the 550 recommended products are mineral-based, indicating a shift in consumer preferences. This trend is driven by the fact that mineral sunscreens are not absorbed into the dermis, reducing the risk of systemic exposure. Despite this, older chemical filters like avobenzone and oxybenzone have been linked to prolonged presence in the bloodstream, raising questions about their long-term safety.

“The approval of a new, safer chemical ingredient for sunscreens is a major breakthrough,” said David Andrews. “It fills a critical gap and sets a new standard for what consumers can expect from their products.” The FDA’s action follows years of scrutiny over the six chemicals identified as potential endocrine disruptors, which remain in the body even after use stops. For example, homosalate and oxybenzone were found to persist in the bloodstream for over two weeks, according to the agency’s 2019 findings. Although manufacturers have been urged to conduct further research, no updated regulations have been implemented to date.

Industry Response and Future Prospects

The Personal Care Products Council (PCPC), which represents sunscreen manufacturers, welcomed the FDA’s decision as a “significant advancement” but called for continued improvements. “While we commend the FDA for this progress, more work is needed to establish a modern framework for approving new active ingredients,” said Tesia Williams, a PCPC spokesperson, in an email. This sentiment reflects the industry’s acknowledgment of the need for innovation while maintaining rigorous safety standards.

For consumers, the addition of BEMT could mean better protection against both UVA and UVB rays without the drawbacks of traditional chemical filters. “Better yet, unlike older non-mineral filters, BEMT can be combined with zinc oxide to provide broad-spectrum protection with less white cast,” Friedman noted. This feature addresses a common complaint about mineral sunscreens, which were historically associated with a visible residue on the skin. Newer formulations, however, have mitigated this issue, making them more appealing to a wider audience.

The FDA’s approval also signals a regulatory shift toward prioritizing safety and efficacy. By recognizing BEMT as GRASE (“generally regarded as safe and effective”), the agency has validated its use in products, providing a benchmark for future evaluations. This move is part of a growing effort to modernize sunscreen standards, as highlighted in the 2026 report. The report suggests that the U.S. lags behind Europe and Asia in adopting advanced UV filters, a gap that BEMT now helps to bridge.

As BEMT becomes available to the public, its impact on the market is expected to be substantial. With more options for consumers, the push for safer and more effective sunscreens is likely to gain momentum. “This is a win that has been a long time coming,” Andrews remarked. The approval not only reflects scientific progress but also aligns with public demand for transparency and innovation in skincare products.

In the years ahead, the integration of BEMT into U.S. sunscreens could redefine the industry’s approach to UV protection. While mineral-based options remain a staple, the addition of this new chemical filter may lead to a hybrid model that combines the best of both worlds. For now, the FDA’s decision serves as a pivotal moment in the ongoing effort to enhance sunscreen quality and consumer confidence.